SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsHighPositive
Announced Fri, 22 May · 14:58 IST

Shilpa Medicare Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, recommended Final Dividend of Rs. 0.60 per equity share.

Corporate Actions View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.1%1-day move
₹476.00
prior close
₹508.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.3-2.7-3.7-4.2+8.1+6.3+3.6+4.0+4.5+8.3+11.9+15.3+28.7
Up moveDown movePending
AI summary

Shilpa Medicare's Board meeting on May 22, 2026 approved audited financial results for FY2025-26. Standalone revenue grew 25% to Rs. 59,703 lakhs while net profit nearly doubled to Rs. 13,297 lakhs compared to Rs. 6,789 lakhs in the previous year. Consolidated revenue reached Rs. 153,887 lakhs with net profit of Rs. 24,333 lakhs. The Board recommended a final dividend of Rs. 0.60 per equity share (60% on face value of Rs. 1/-). The company also plans to shift its registered office from Karnataka to Maharashtra and its subsidiaries will invest Rs. 4.44 crore for a 28% equity stake in Neo Green Power Project Private Limited, a renewable energy company being acquired for captive power consumption.

Likely market impact

Strong financial performance with near-doubling of standalone net profit is positive for shareholders. The modest Rs. 0.60 dividend reflects retention of earnings for growth. The renewable energy investment signals diversification into green energy for operational cost savings.